Jennersville Hospital, LLC
Jennersville Hospital, LLC was paid $1.35M by Medicaid between Aug 2019 and Dec 2021, across 63 billing codes. Its largest line is 99284, emergency room visit (serious) — 34% of everything it billed.
WEST GROVE, PA 19390
Next to other General Acute Care Hospital providers in Pennsylvania
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 306 | $9K | |
| 2020 | 4,317 | $251K | |
| 2021 | 13,610 | $1.09M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 34% | 2,196 | 1,993 | $458K |
| G0378 | Hospital observation service, per hour | 16% | 292 | 257 | $221K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 15% | 1,725 | 259 | $199K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 949 | 849 | $169K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10% | 583 | 567 | $142K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.6% | 174 | 170 | $35K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.6% | 64 | 64 | $21K |
| 71046 | Radiologic examination, chest; 2 views | 1.1% | 252 | 243 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 462 | 442 | $11K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | 12 | $9K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 208 | 194 | $9K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 64 | 64 | $8K |
51 more codes
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 32 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 752 | $5K |
| 73630 | <1% | 33 | $5K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,058 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,689 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 171 | $5K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 127 | $3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 33 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 384 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 453 | $2K |
| 84703 | <1% | 367 | $2K | |
| 87631 | <1% | 57 | $2K | |
| 84484 | <1% | 536 | $2K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 360 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 288 | $1K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 133 | $1K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 238 | $900.55 |
| 71045 | Radiologic examination, chest; single view | <1% | 278 | $763.19 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 755 | $674.71 |
| 81001 | <1% | 311 | $533.47 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $458.97 |
| 83735 | <1% | 217 | $440.22 | |
| 83690 | <1% | 225 | $403.52 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 38 | $373.23 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 162 | $343.91 |
| 81003 | <1% | 289 | $324.93 | |
| 85610 | <1% | 200 | $313.62 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 264 | $229.73 |
| 96376 | <1% | 18 | $228.06 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 81 | $183.68 |
| 87040 | <1% | 24 | $171.42 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 71 | $138.00 |
| 82962 | <1% | 235 | $120.04 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 128 | $104.67 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 75 | $94.28 |
| 82550 | <1% | 29 | $86.28 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 255 | $78.72 |
| 83605 | <1% | 30 | $67.20 | |
| 94760 | <1% | 118 | $65.84 | |
| J3490 | Unclassified drugs | <1% | 67 | $34.31 |
| 85730 | <1% | 14 | $30.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 47 | $10.76 |
| 87186 | <1% | 13 | $8.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 16 | $7.54 |
| 87077 | <1% | 13 | $7.10 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $4.02 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 35 | $3.27 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 19 | $1.83 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 46 | $1.64 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 16 | $0.00 |
| 00000 | 0% | 425 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Chestnut Hill Hospital, LLC | Philadelphia, PA | $9.52M |
| Brandywine Hospital, LLC | Coatesville, PA | $2.97M |
| West Grove Clinic Company LLC | West Grove, PA | $157K |
| Tower Health Medical Group | Wyomissing, PA | $98K |
| Tower Health Medical Group | Wyomissing, PA | $84K |
| STC Pediatrics LLC | Philadelphia, PA | $24K |
| Tower Drexel Academic Medical Group LLC | Philadelphia, PA | $18K |
| Tower Health Urgent Care, LLC | Kennett Square, PA | $9K |
| Tower Health Urgent Care, LLC | Philadelphia, PA | $8K |
| Tower Health Urgent Care, LLC | Philadelphia, PA | $4K |
| Tower Health Urgent Care, LLC | Doylestown, PA | $3K |
| Tower Health Medical Group | West Reading, PA | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.